Browsing Tag

Repertoire Immune Medicines

1 post

Repertoire Immune Medicines is a clinical-stage biotechnology firm developing medicines that unlock and utilize the massive potential of the human immune system to prevent or treat cancer, as well as autoimmune and viral diseases.

Repertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery T Cell Receptors

Biotech NewsRepertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery & T Cell Receptors

BioTech Health X
April 29, 2021

The collaboration between Repertoire and Yale seeks to identify novel antigenic reactivity of T cells in patients with…

Repertoire Immune Medicines

Biotech NewsRepertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery & T Cell Receptors

Here’s Why Eli Lilly (LLY) is the Pharma Stock Everyone is Talking About Right Now

Tonix Pharma (TNXP) Jumps 14% – Here’s What You Need to Know

Wall Street’s Best-Kept Biotech Secret: Crinetics (CRNX) Could Be the Next 10X Stock!

Forget Glasses—Lenz Therapeutics (LENZ) Just Got FDA Approval for a Daily Eye Drop Fix

$2.3 Billion Potential? Why Kymera Therapeutics (KYMR) Might Be the Biggest Sleeper Stock in Biotech

From $0 to $300M+ in Sales: Mirum Pharmaceuticals (MIRM)’s Wild Ride Is Just Beginning

Nutriband (NTRB): The #1 Biotech That Could 10x by Solving America’s Opioid Problem

Big Pharma Should Be Nervous — Xeris (XERS) Just Cracked the Code on Drug Delivery

Hello, I’m
BioTech Health X

Subscribe toOur Updates

Subscribe to
Our Updates